Getty Images to Capture Breathtaking Visuals from the Paris 2024 Paralympic Games
NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) — Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, today announced […]
Gray Media Announces Coverage Plans for 2024 Democratic National Convention
ATLANTA, Aug. 19, 2024 (GLOBE NEWSWIRE) — Gray Media (NYSE: GTN) today announced comprehensive coverage plans for the 2024 Democratic […]
MariMed Announces Opening of Second Maryland Dispensary
NORWOOD, Mass., Aug. 19, 2024 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state […]
Global Helium Corp. Provides Update on North American Helium’s Test Well
CALGARY, Alberta, Aug. 19, 2024 (GLOBE NEWSWIRE) — Global Helium Corp. (“HECO” or the “Company”) (CSE: HECO, OTC: HECOF) provides […]
Next Hydrogen to Supply Latest Generation Electrolysis Technology for Renewable Energy Ammonia Production Research
MISSISSAUGA, Ontario, Aug. 19, 2024 (GLOBE NEWSWIRE) — Next Hydrogen Solutions Inc. (the “Company” or “Next Hydrogen“) (TSXV:NXH, OTC:NXHSF), a designer […]
TSX News -
Endeavour Silver Provides Update on Guanacevi Trunnion Failure
VANCOUVER, British Columbia, Aug. 19, 2024 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) […]
NAR Rule Changes – reAlpha’s Growth Opportunities
DUBLIN, Ohio, Aug. 19, 2024 (GLOBE NEWSWIRE) — reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), a real estate technology […]
AMD to Significantly Expand Data Center AI Systems Capabilities with Acquisition of Hyperscale Solutions Provider ZT Systems
— Strategic acquisition to provide AMD with industry-leading systems expertise to accelerate deployment of optimized rack-scale solutions addressing $400 billion […]
Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights
On track to submit NDA in second half 2024 for TNX-102 SL for fibromyalgia; completed successful pre-NDA meetings with FDA […]
U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
FDA confirmed that the amendment to add PH-ILD to the YUTREPIA NDA was proper and that application otherwise meets the […]
